secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2023-05-26T23:59:59+00:00
Accession:  0001493152-23-019340
Event type: leadership
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera names Hermann Luebbert CEO; director Loretta Wedge resigns citing board disputes
--------------------------------------------------------------------------------

- Appointed Hermann Luebbert (Executive Chairman) as CEO, succeeding Erica Monaco; Luebbert remains Chairman.
- Erica Monaco receives $450K severance (less May 8–26 salary), paid through Jan 2024 then lump sum; 1-yr non-compete.
- Director Loretta Wedge resigned May 22, citing disagreements on management transition and strategic direction; company disputes her claims.
- Nasdaq non-compliance for audit committee composition cured by appointing John Borer to audit committee as financial expert.
- Shareholders approved reverse stock split (1:5 to 1:25) and proportional authorized share reduction; board may implement by Aug 23, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315223019340/0001493152-23-019340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315223019340/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-019340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer